
![]() |
![]() |
B |
![]() |
![]() |
Prince Ngongo Bahati
|
Ending AIDS: The role of New Prevention Technologies in an evolving epidemic in Africa; December 4, 2014; This Program is Available for CME Credit |
![]() |
Laura P. Bamford, MD, MSCE
|
Primary HIV medical care within a syringe exchange program in North Philadelphia; February 19, 2015; This Program is Available for CME Credit |
![]() |
John G. Bartlett, MD
Chief, Division of Infectious Diseases |
Update from the 20th Conference on Retroviruses and Opportunistic Infections; John G. Bartlett, MD; March 21st, 2013; 0100-HIVGR3 Week 34 THIS PROGRAM IS NO LONGER AVAILABLE FOR CME CREDIT Antiretroviral Therapy: What to Start? October 6th, 2010; 0002-HIVGR1 Week 2; THIS PROGRAM IS NO LONGER AVAILABLE FOR CME CREDIT |
![]() |
Todd D. Barton, MD
Asscociate Professor of Clinical Medicine |
Real Cases from the Hospital of the University of Pennsylvania: "Preventable" Lung Disease in HIV Infected Patients; with: Todd Barton, MD & Valerianna Amorosa, MD; March 1st, 2012; 0059-HIVGR2 Week 33 THIS PROGRAM IS NO LONGER AVAILABLE FOR CME CREDIT Real Cases from the Hospital of the University of Pennsylvania- Syphilis, HCV; with: Pablo Tebas, MD & Ian Frank, MD; June 29th, 2011; 0034-HIVGR2 Week 8; THIS PROGRAM IS NO LONGER AVAILABLE FOR CME CREDIT |
|
Joseph Berger, MD
|
Progressive Multifocal Leukoencephalopathy: Lessons from AIDS and Natalizumab; November 13, 2014; THIS PROGRAM IS AVAILABLE FOR CME CREDIT |
![]() |
Michael R. Betts, PhD
Associate Professor |
CD8+ T-cell Mediated Control of HIV Throughout HIV Infection; December 1st, 2011; 0049-HIVGR2 Week 23 THIS PROGRAM IS NO LONGER AVAILABLE FOR CME CREDIT |
![]() |
Chris Beyrer, MD, MPH
Professor |
The Global Epidemics of HIV Among MSM: Changing Prevention Approaches; December 15th, 2011; 0051-HIVGR2 Week 25 THIS PROGRAM IS NO LONGER AVAILABLE FOR CME |
![]() |
Gregory P. Bisson, MD MSCE
Assistant Professor of Epidemiology |
From Insolation to Ibuprofen: Emerging concepts in Host-directed therapy for TB; February 12, 2015 Topic: Tuberculosis and HIV: Epidemiology, Prevention and When to Start Antiretroviral Therapy; March 30th, 2011; 0022-HIVGR1 Week 22 THIS PROGRAM IS NO LONGER AVAILABLE FOR CME CREDIT HIV Case Studies from the Hospital of the University of Pennsylvania - Renal Disease, TB, Pharmacokinetics; with: Christopher Vinnard, MD, Deirdre Sawinski, MD & Ian Frank, MD; March 16th, 2011; 0020-HIVGR1 Week 20 THIS PROGRAM IS NO LONGER AVAILABLE FOR CME |
|
Pamela Bjorkman, PhD
Max Delbruck Professor of Biology and Investigator, Howard Hughes Medical Institute |
Engineering better HIV antibodies using structure-based design; September 19th, 2013; THIS PROGRAM IS NO LONGER AVAILABLE FOR CME CREDIT |
![]() |
Jason Brenchley, PhD
Senior Investigator, Viral Pathogenesis and Vaccine Section |
Mechanisms Underlying Different Outcomes in Primate Lentiviral InfectionsMechanisms Underlying Different Outcomes in Primate Lentiviral Infections; December 16th, 2010; 0011-HIVGR1 Week 11 THIS PROGRAM IS NO LONGER AVAILABLE FOR CME |
![]() |
Todd T. Brown, MD PhD
Assistant Professor of Medicine |
Osteoporosis in the HIV-infected Patient: Current Concepts and Controversies; January 30th, 2014; This Program is No Longer available for CME credit Osteoporosis in the HIV-Infected Patient; December 8th, 2010; 0010-HIVGR1 Week 10 THIS PROGRAM IS NO LONGER AVAILABLE FOR CME CREDIT |